Submission of Annual Secretarial Compliance Report for the year ended 31st March. 2026.
Compliances-Reg.24(A)-Annual Secretarial Compliance
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Apr 23 2026
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Apr 03 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Mar 26 2026
- Closure of Trading Window
Later from Welcure Drugs and Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 01 2026
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Friday, 19Th June, 2026
- Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 19 2026
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals